A naukri.com initiative
Hitconsultant
1M
117
Image Credit: Hitconsultant
The Future of Mobility: Wandercraft Raises $75M for Self-Balancing Exoskeletons
- Wandercraft, a leader in self-balancing robotic mobility systems, secures $75M in Series D funding.
- Major contributors to the funding round include Renault Group, PSIM fund managed by Bpifrance, Teampact Ventures, and Quadrant Management.
- Wandercraft is known for creating the world's first self-balancing walking exoskeleton, Atalante X, used in over 100 rehabilitation centers globally.
- The funding will drive development in three key areas: introducing Eve personal exoskeleton, expanding Atalante X adoption, and developing Calvin-40 for industrial applications.
- Renault Group now holds a minority stake in Wandercraft, aiding in scaling up exoskeleton production and supporting the development of humanoid robots.
- Renault Group is also Wandercraft's first commercial partner for Calvin-40, a humanoid robot developed in just 40 days using NVIDIA Isaac technologies.
- Recent milestones include FDA clearances for Atalante X, deployment in 100+ hospitals globally, launching clinical trials for Eve personal exoskeleton, enabling 2,500 individuals to take over 14 million steps, and winning a 2025 SXSW Innovation Award.
- Wandercraft's CEO, Matthieu Masselin, highlights the company's global expansion, clinical trials, upcoming Eve commercialization, and partnership with Renault Group.
Read Full Article
7 Likes
For uninterrupted reading, download the app